Cargando…
COVID-19 Vaccines for Optimizing Immunity in the Upper Respiratory Tract
Rapid development and deployment of vaccines greatly reduced mortality and morbidity during the COVID-19 pandemic. The most widely used COVID-19 vaccines approved by national regulatory authorities require intramuscular administration. SARS-CoV-2 initially infects the upper respiratory tract, where...
Autor principal: | Ramasamy, Ranjan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10674974/ https://www.ncbi.nlm.nih.gov/pubmed/38005881 http://dx.doi.org/10.3390/v15112203 |
Ejemplares similares
-
Innate and Adaptive Immune Responses in the Upper Respiratory Tract and the Infectivity of SARS-CoV-2
por: Ramasamy, Ranjan
Publicado: (2022) -
Tuberculosis of the Upper Respiratory Tracts
Publicado: (1941) -
Upper respiratory tract microbiota dynamics following COVID-19 in adults
por: Rosas-Salazar, Christian, et al.
Publicado: (2023) -
Diseases of the Upper Respiratory Tract
Publicado: (1901) -
Diseases of the Upper Respiratory Tract
Publicado: (1895)